Cerebrospinal fluid neurofilament light chain and tau protein were found as mortality biomarkers in parkinsonism, including PSP, but it was unable to tell the difference among each specific parkinsonian type (19). The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.